High-Intensity Interval Training in Low Versus Normal Oxygen: Effects on Body Fat and Gut Health in Adults Aged 50-75 With Overweight or Obesity (HYPOXFAT)
HYPOXFAT
High-intensity Interval Training Under Hypoxic Versus Normoxic Conditions: Effects on Fat Mass Loss and Gut Microbiota in Adults Aged 50-75 With Overweight or Obesity
1 other identifier
interventional
32
1 country
1
Brief Summary
Overweight and obesity are major public health challenges worldwide, and their prevalence increases with age, partly because of age-related metabolic and hormonal changes. Beyond total fat mass, abdominal and particularly visceral fat accumulation is strongly associated with chronic low-grade inflammation, insulin resistance, hypertension and cardiovascular disease. Men are more likely to display an android fat distribution, while premenopausal women generally show a more protective gynoid distribution. However, declining sex hormone concentrations after menopause promote abdominal and visceral fat accumulation, increasing cardiometabolic risk. Physical activity is a cornerstone of overweight and obesity management. High-intensity interval training (HIIT) is an effective strategy for reducing total, abdominal and visceral fat and may produce greater benefits than moderate-intensity continuous training. Since 2016, our team has conducted several studies and reviews showing that HIIT performed on a cycle ergometer or treadmill, alone or combined with resistance training, reduces total and abdominal fat mass in people with overweight or obesity, regardless of age, sex or hormonal status. HIIT can also be performed under real or simulated hypoxic conditions to enhance cardiovascular, respiratory, circulatory, haematological and skeletal muscle adaptations. The Live Low-Train High model allows participants to live under normoxic conditions while being exposed to hypoxia only during exercise. Hypoxic HIIT has proved feasible and safe in people with metabolic disorders or physical deconditioning, including at simulated altitudes of 4,000-5,000 m. However, only two studies have suggested that hypoxic HIIT may enhance fat mass loss in people with overweight or obesity. Neither specifically assessed abdominal or visceral fat, and neither focused on postmenopausal women. Several mechanisms may contribute to HIIT-induced fat loss, including increased catecholaminergic stimulation and lipid oxidation during recovery, excess post-exercise oxygen consumption and changes in appetite regulation. The gut microbiota may also contribute to the regulation of adipose tissue and cardiometabolic health. Physical activity can increase bacterial diversity and promote beneficial taxa, particularly short-chain fatty acid-producing bacteria. Our previous HIIT studies identified associations between changes in selected bacteria and reductions in total or abdominal fat mass. Hypoxic exposure may also alter gut microbiota composition and abundance, with effects depending on the severity and type of hypoxia. This study will assess the effects of a 3-month cycle-ergometer HIIT programme, performed three times per week under hypoxic versus normoxic conditions, in adults aged 50-75 years with overweight or obesity. The primary objective is to determine whether hypoxic HIIT produces a greater reduction in abdominal and visceral fat mass than the same training performed in normoxia. Secondary outcomes will include total and regional fat and lean mass; fasting glucose, insulin, HbA1c and HOMA-IR; total cholesterol, triglycerides, HDL-C, LDL-C, ApoB, ApoA1 and the ApoB/ApoA1 ratio; high-sensitivity C-reactive protein and fibrinogen; systolic and diastolic blood pressure; blood biophysical properties; and faecal microbiota richness, diversity and taxonomic composition. Lipid oxidation during prolonged moderate-intensity exercise, maximal oxygen uptake and maximal aerobic power will also be assessed before and after the intervention. We hypothesise that hypoxic training will enhance improvements in body composition, metabolic and cardiovascular risk factors, aerobic fitness and lipid oxidation compared with normoxic training. We further hypothesise that hypoxia will modify faecal microbiota composition and that changes in selected bacterial taxa will be associated with changes in body composition and cardiovascular risk markers. The ultimate aim is to improve the management of adults aged 50-75 years with overweight or obesity by developing an effective 3-month HIIT programme performed under controlled hypoxic conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 26, 2026
CompletedFirst Submitted
Initial submission to the registry
August 27, 2026
CompletedFirst Posted
Study publicly available on registry
September 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 5, 2028
September 1, 2026
August 1, 2026
1.9 years
August 27, 2026
August 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relative Change in Total Abdominal Fat Mass
Total abdominal fat mass will be measured by dual-energy X-ray absorptiometry (DXA) at baseline and after the 12-week intervention. The relative change will be calculated as: (abdominal fat mass at 12 weeks - abdominal fat mass at baseline) / abdominal fat mass at baseline. More negative values indicate a greater reduction in abdominal fat mass. The change will be compared between the hypoxic and normoxic HIIT groups.
Baseline and immediately after the 12-week intervention
Secondary Outcomes (14)
Relative Change in Body Mass
Baseline and after 12 weeks of intervention
Relative Change in Visceral Abdominal Fat Mass
Baseline and after 12 weeks of intervention
Relative Change in Total Lean Mass
Baseline and after 12 weeks of intervention
Relative Change in Waist-to-Hip Ratio
Baseline and after 12 weeks of intervention
Relative Change in metabolic Plasma parameters (TG, HBA1C, glucose, insulin, HDL, LDL)
Baseline and after 12 weeks of intervention
- +9 more secondary outcomes
Study Arms (2)
Hypoxic HIIT (HIIT-H)
EXPERIMENTALParticipants will complete a 12-week cycle-ergometer HIIT programme, with three sessions per week, under normobaric hypoxia (FiO₂: 15%; simulated altitude: 3,000 m).
Normoxic HIIT (HIIT-N)
ACTIVE COMPARATORParticipants will complete the same 12-week cycle-ergometer HIIT programme, with three sessions per week, under normoxic conditions (FiO₂: 21%).
Interventions
Participants will complete 36 cycle-ergometer HIIT sessions over 12 weeks (three sessions per week) under normoxic conditions (FiO₂: 21%). Each session will include a 5-minute warm-up followed by 60 repetitions of 8 seconds of acceleration at approximately 80-85 rpm and 12 seconds of deceleration at approximately 60 rpm. The 8-second efforts will be performed at 75-80% of maximal aerobic power.
Participants will complete 36 cycle-ergometer HIIT sessions over 12 weeks (three sessions per week) under normobaric hypoxia (FiO₂: 15%; simulated altitude: 3,000 m). Each session will include a 5-minute warm-up followed by 60 repetitions of 8 seconds of acceleration at approximately 80-85 rpm and 12 seconds of deceleration at approximately 60 rpm. The 8-second efforts will be performed at 75-80% of maximal aerobic power.
Eligibility Criteria
You may qualify if:
- Aged 50-75 years, inclusive Male or postmenopausal female, defined as no menstruation during the previous 12 months Body mass index between 25 and 35 kg/m², inclusive Non-smoker or smoking no more than two cigarettes per day Stable body weight for at least three months before study initiation, defined as a change of less than 4 kg Stable dietary habits and physical activity level for at least three months before study initiation Willing to maintain usual dietary habits and physical activity level throughout the study Able and willing to comply with the study protocol Able and willing to provide written informed consent Affiliated with a social security scheme Willing to be registered in the French National Register of Volunteers Participating in Biomedical Research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CREPS Auvergne Rhône-Alpes / Vichy
Bellerive-sur-Allier, 03321, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 27, 2026
First Posted
September 1, 2026
Study Start
August 26, 2026
Primary Completion (Estimated)
July 5, 2028
Study Completion (Estimated)
July 5, 2028
Last Updated
September 1, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share